Fahie, MAV, Hoffman JG, Kay MS, Kardon JR. HAX1 drives assembly and activation of the mitochondrial intermembrane space chaperone CLPB. bioRxiv 2026.05.24.727526; doi: https://doi.org/10.64898/2026.05.24.727526
The multicellular metazoan lineage acquired a novel chaperone in the mitochondrial intermembrane space, the AAA+ disaggregase and refoldase CLPB. Although it was not known how they function together, CLPB and the intrinsically disordered IMS protein HAX1 interact and their loss of function cause similar disease and cellular phenotypes, including congenital neutropenia, neuropathology, and increased protein insolubility in the IMS and its bounding membranes. In this study, we determined that HAX1 is a direct stimulatory cofactor of CLPB. HAX1 promotes oligomerization of CLPB into an active disaggregase and stimulates the ATPase and refoldase activities of the oligomeric complex. HAX1 shifts the predominant oligomeric state of CLPB from a dodecamer to an apparent hexamer elaborated with HAX1, suggesting that this smaller oligomer is important during the cycle of CLPB function with clients.
Cottle T*, Joh L*, Posner C*, DeCosta A, Campagna DR, Fleming MD, Ducamp S, Kardon JR†. An adaptor for feedback regulation of heme biosynthesis by a mitochondrial protease. Science 2026 Jul 30;393(6810):eads5397. doi: 10.1126/science.ads5397. *equal contribution †corresponding author
(previously bioRxiv https://doi.org/10.1101/2024.07.05.602318)
CLPXP degrades ALAS in response to heme, a negative feedback mechanism to prevent heme oversupply and porphyrin precursor accumulation. Through biochemical reconstitution, we discovered that this feedback mechanism requires an additional, heme-sensitive adaptor protein, POLDIP2. Degradation requires the C-terminal element of ALAS. We propose that this serves as the site for initiation of unfolding, providing a bivalent signal for degradation that is perturbed in several forms of erythropoietic protoporphyria. Loss of POLDIP2 or this C-terminal element in ALAS causes accumulation of ALAS in developming erythrocytes, resulting in the accumulation of protoporphyrin IX that is characteristic of erythropoietic protoporphyria.
Left: AlphaFold3 model of the MI of S. cerevisiae ClpX (Mcx1) in blue, with key elements colored in orange and green, projecting from the AAA+ domain (gray). Right: Deletion or mutation of the MI perturbs recruitment and engagement of ALAS by Mcx1.
DeCosta A, Barrick R, Kardon JR. A mitochondrial insertion directs substrate selection and engagement by the protein unfoldase ClpX. Journal of Biological Chemistry 2026, doi: https://doi.org/10.1016/j.jbc.2026.113539
(previously bioRxiv https://doi.org/10.64898/2026.02.23.707539)
The force-generating AAA+ ATPase domain of protein unfoldases is specified for many substrates and other functional partners through elaboration with accessory domains. Mitochondrial homologs of the unfoldase ClpX contain an insertion within the AAA+ domain that is absent in bacterial homologs. We find that the MI is critical for both recruitment and activation of ALAS by S. cerevisiae ClpX. The MI was dispensable for heme-induced, adaptor-mediated degradation of ALAS by human CLPXP, but contributed to adaptor-independent recruitment of the model substrate casein for degradation. Although truncation of the MI moderately perturbed ATPase activity in both yeast and human ClpX, this effect could be uncoupled from the requirement for the MI in the efficiency of ALAS activation by targeted mutagenesis. The MI therefore can serve both to recruit a substrate to mitochondrial ClpX and to accelerate its processing by the AAA+ motor.
*Kardon, J. R., Moroco, J. A., Engen, J. R., *Baker, T. A. (2018) Mitochondrial ClpX activates an essential biosynthetic enzyme through partial unfolding eLife 2020; 9:e54387 *co-corresponding author
In this manuscript, we used mutagenesis, biochemical reconstitution, and functional assays in vivo to describe a multivalent recognition and grip site in ALA synthase. Using hydrogen-deuterium exchange (in collaboration with John Engen's group, NEU) we observed that mitochondrial ClpX uses this site to initiate a specific partial unfolding of ALA synthase that exposes the active site, thus helping ALA synthase to bind its PLP cofactor and become active.
Kardon, J. R., Yien, Y. Y., Huston, N. C., Branco, D. S., Hildick-Smith, G. J., Rhee, K. Y., Paw, B. H., Baker, T. A. (2015) Mitochondrial ClpX activates a key enzyme for heme biosynthesis and erythropoiesis. Cell 161(4):858-67
This paper describes our discovery of the mitochondrial unfoldase ClpX as an activator of the initial enzyme in heme biosynthesis, ALA synthase. Using genetics and metabolite profiling, we found that ClpX promotes the first step in heme biosynthesis, the synthesis of aminolevulinic acid (ALA). We additionally found that this function of ClpX is important for sustaining the high heme production necessary for red blood cell development (in collaboration with the Paw group, HMS). Through biochemical reconstitution, we determined that ClpX directly activates ALA synthase by facilitating ALA synthase-cofactor complex formation.
Yien, Y. Y., Ducamp, S., *van der Vorm, L. N., *Kardon, J. R.,Manceau, H., Kannengiesser, C., Bergonia, H. A., Kafina, M. D., Karim, Z., Gouya, L., Baker, T. A., Puy, H., Phillips, J. D., Nicolas, G. & Paw, B. H. (2017) Mutation in human CLPX elevates levels of δ-aminolevulinate synthase and protoporphyrin IX to promote erythropoietic protoporphyria. PNAS114:E8045–E8052 *co-second authors
This highly collaborative study combined human genetics, cell model systems for erythropoiesis, and biochemistry to describe mitochondrial ClpX as a new causative allele in erythropoietic protoporphyria. Surprisingly, a heterozygous loss-of-function allele of ClpX results in hyperstimulated heme biosythesis due to reduced degradation of ALA synthase. This result corroborates another recent report of ClpX-dependent degradation of ALA synthase that is triggered by heme binding, suggesting a possible feedback mechanism that switches ClpX from activation to degradation of ALA synthase when heme levels are too high.